(Q37869258)

24 August 2017

1 reference

title

Linezolid pharmacokinetics and pharmacodynamics in clinical treatment (English)

1 reference

24 August 2017

1 reference

1 reference

1 reference

Matthew S Dryden

1

1 reference

PubMed ID

21521707

24 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

Journal of Antimicrobial Chemotherapy

24 August 2017

1 reference

24 August 2017

66 Suppl 4

1 reference

24 August 2017

iv7-iv15

1 reference

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections

24 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Pharmacokinetics and tissue penetration of linezolid following multiple oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

A pharmacokinetic evaluation of concomitant administration of linezolid and aztreonam

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

The effect of food on plasma and tissue concentrations of linezolid after multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Effect of severity of sepsis on tissue concentrations of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Potential subtherapeutic linezolid and meropenem antibiotic concentrations in a patient with severe burns and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Role of linezolid in the treatment of orthopedic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid for the treatment of adults with bone and joint infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid penetration into osteo-articular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Intrapulmonary pharmacokinetics of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Clostridium difficile in food--innocent bystander or serious threat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid pharmacokinetics in adult patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Pharmacokinetics of linezolid in subjects with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Clinical experience with recently approved antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Vancomycin-resistant Enterococcus faecium meningitis successfully treated with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

The pharmacokinetics of linezolid in the non-inflamed human eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Impact of ontogeny on linezolid disposition in neonates and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Linezolid pharmacokinetics in pediatric patients: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR072

21 January 2018

Identifiers

DOI

10.1093/JAC/DKR072

1 reference

24 August 2017

1 reference

PubMed ID

21521707